Now what?

Now what?

As much as we should be shocked by this Tandem (NASDAQ: TNDM) did complete their offering. Per an 8-K filed with the SEC “On March 28, 2017, Tandem Diabetes Care, Inc. (the “Company”) closed the previously announced underwritten public offering of its common stock. In the offering, the Company sold an aggregate of 18,500,000 shares of its common stock at a public offering price of $1.25 per share. The gross proceeds to the Company from the offering were $23.1 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.